ROR1 associates unfavorable prognosis and promotes lymphoma growth in DLBCL by affecting PI3K/Akt/mTOR signaling pathway

BioFactors
Yuan MaoJiaren Xu

Abstract

The receptor-tyrosine-kinase (RTK)-like orphan receptor 1 (ROR1) is a transmembrane glycoprotein regarded as a tumor-associated antigen. ROR1 plays an important role in cancer development, but the detailed function of ROR1 in diffuse large B-cell lymphoma (DLBCL) remains unclear. In this study, we first detected ROR1 expression and evaluated the relationship between ROR1 expression and the clinicopathological characteristics of DLBCL patients. Next we employed shRNA-mediated knockdown of ROR1 in DLBCL cell line to explore the characteristics of ROR1 in DLBCL development both in vitro and in vivo. The results showed a significantly higher level of ROR1 in DLBCL tissues than in lymphatic hyperplasia tissues. High ROR1 expression was correlated with unfavorable prognosis in DLBCL patients. Furthermore, ROR1 knockdown inhibited the growth and induced the apoptosis in DLBCL cells and xenografts. In addition, shROR1 inhibited activation of the PI3K/Akt/mTOR signaling pathway, both in vitro and in vivo. Taken together, our results suggest that ROR1 is a novel prognostic marker for DLBCL survival and ROR1 significantly promotes DLBCL tumorigenesis by regulating the PI3K/Akt/mTOR signaling pathway. Targeting ROR1 may provide a promising...Continue Reading

References

Jul 15, 2005·The New England Journal of Medicine·Daniela S Krause, Richard A Van Etten
Oct 14, 2008·Trends in Cell Biology·Jennifer L GreenPaul W Sternberg
Jul 3, 2010·Hematological Oncology·Gábor BarnaAndrás Matolcsy
Apr 14, 2011·Cancer Research·Alessandra GentilePaolo M Comoglio
Dec 14, 2011·Hematology·Jonathan W Friedberg
Sep 20, 2012·Leukemia & Lymphoma·Amir Hossein DaneshmaneshAnders Österborg
Oct 9, 2012·The American Journal of Pathology·Suping ZhangThomas J Kipps
Aug 28, 2013·Virchows Archiv : an International Journal of Pathology·Renjie ChenJiaren Xu
Aug 29, 2013·International Journal of Cancer. Journal International Du Cancer·Hong LinZhenqing Feng
Dec 18, 2013·Pharmacology & Therapeutics·Jiri Polivka, Filip Janku
Jul 25, 2014·Scientific Reports·Huilin ZhangJin Zhu
Jul 30, 2014·Seminars in Cancer Biology·Mohammad Hojjat-FarsangiHåkan Mellstedt
Sep 13, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Agata MajchrzakPiotr Smolewski
Apr 4, 2015·Expert Opinion on Therapeutic Targets·Mahdi ShabaniFazel Shokri
Aug 25, 2015·Clinical Lymphoma, Myeloma & Leukemia·Michael Y ChoiThomas J Kipps
Oct 29, 2015·Molecular Carcinogenesis·Natalia Brenda FernándezPablo Lopez-Bergami
Jan 26, 2016·CA: a Cancer Journal for Clinicians·Wanqing ChenJie He
Feb 15, 2016·Virchows Archiv : an International Journal of Pathology·Hui-Ping ChienChuen Hsueh
Mar 1, 2016·Cell Biochemistry and Function·Eun-Hwa JungChan-Wha Kim
Nov 11, 2016·Scientific Reports·Yu-Zhu ZhengYong Peng
Nov 18, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ashwini BalakrishnanStanley R Riddell
Feb 6, 2017·Lancet·James O ArmitageFranco Cavalli
Apr 15, 2017·Biochemical Society Transactions·Hanna KarvonenDaniela Ungureanu
Mar 5, 2018·International Journal of Surgery·Kuo-Hung HuangMuh-Hwa Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Zhonghua bing li xue za zhi Chinese journal of pathology
Yan ZhengYin-Ping Wang
Zhonghua zhong liu za zhi [Chinese journal of oncology]
Bo-yan YangSong-niang Meng
© 2022 Meta ULC. All rights reserved